A live and archived webcast of the event will be available on the “Investors” section of the Pulmonx website at About Pulmonx Corporation Pulmonx Corporation (Nasdaq: LUNG) is a global leader in ...
AstraZeneca's hopes of a big new indication for respiratory drug Fasenra in chronic obstructive pulmonary disease (COPD) have been dashed by a negative phase 3 trial. The RESOLUTE study of IL-5 ...
Guam Regional Medical City will be hosting this Saturday a free outreach aimed at raising awareness about lung health, including asthma, chronic obstructive pulmonary disease, COPD, and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results